Team:British Columbia/Human Practices
From 2012.igem.org
(Difference between revisions)
Line 7: | Line 7: | ||
*IP [https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdHdMb09iNDNaYV95TllLazFNTmdCQlE Survey] | *IP [https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdHdMb09iNDNaYV95TllLazFNTmdCQlE Survey] | ||
*IP Survey [https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdC1QTTVoXzdHc0pZY0RxTFBOcy1Bb1E Results] | *IP Survey [https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdC1QTTVoXzdHc0pZY0RxTFBOcy1Bb1E Results] | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
*[http://biobricks.org/bpa/faq/ biobrick agreement] | *[http://biobricks.org/bpa/faq/ biobrick agreement] | ||
===Previous iGEM work=== | ===Previous iGEM work=== |
Latest revision as of 18:40, 25 September 2012
Contents |
Intellectual Property
Previous iGEM work
2011 UQ-australia [http://classic.the-scientist.com/blog/display/53835/ 2010 The Scientist Article] 2010 Caltech [http://igem.uwaterloo.ca/share/Outreach/Human%20Practices%202010/Role%20of%20Biotech%20IPR%20in%202030.pdf 2010 Waterloo] 2007 Edinburgh 2008 UCSF
Community Outreach
OSLI feedback
- Biosafety
- Efficiency
- Environmental